Khlebnikov AI - Search Results

1

Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

Giovannoni MP, Schepetkin IA, Cilibrizzi A, Crocetti L, Khlebnikov AI, Dahlgren C, Graziano A, Dal Piaz V, Kirpotina LN, Zerbinati S, Vergelli C, Quinn MT. Giovannoni MP, et al. Among authors: khlebnikov ai. Eur J Med Chem. 2013 Jun;64:512-28. doi: 10.1016/j.ejmech.2013.03.066. Epub 2013 Apr 8. Eur J Med Chem. 2013. PMID: 23685570 Free PMC article.

2

Modeling of the anticancer action for radical derivatives of nitroazoles: quantitative structure-activity relationship (QSAR) study.

Khlebnikov A, Schepetkin I, Kwon BS. Khlebnikov A, et al. Cancer Biother Radiopharm. 2002 Apr;17(2):193-203. doi: 10.1089/108497802753773810. Cancer Biother Radiopharm. 2002. PMID: 12030113

3

Quantitative structure-activity relationships for small non-peptide antagonists of CXCR2: indirect 3D approach using the frontal polygon method.

Khlebnikov AI, Schepetkin IA, Quinn MT. Khlebnikov AI, et al. Bioorg Med Chem. 2006 Jan 15;14(2):352-65. doi: 10.1016/j.bmc.2005.08.026. Epub 2005 Sep 22. Bioorg Med Chem. 2006. PMID: 16182534

4

Decomposition of reactive oxygen species by copper(II) bis(1-pyrazolyl)methane complexes.

Schepetkin I, Potapov A, Khlebnikov A, Korotkova E, Lukina A, Malovichko G, Kirpotina L, Quinn MT. Schepetkin I, et al. J Biol Inorg Chem. 2006 Jun;11(4):499-513. doi: 10.1007/s00775-006-0101-1. Epub 2006 Apr 22. J Biol Inorg Chem. 2006. PMID: 16680452

5

Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.

Schepetkin IA, Khlebnikov AI, Kirpotina LN, Quinn MT. Schepetkin IA, et al. Among authors: khlebnikov ai. J Med Chem. 2006 Aug 24;49(17):5232-44. doi: 10.1021/jm0605132. J Med Chem. 2006. PMID: 16913712

6

Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.

Khlebnikov AI, Schepetkin IA, Domina NG, Kirpotina LN, Quinn MT. Khlebnikov AI, et al. Bioorg Med Chem. 2007 Feb 15;15(4):1749-70. doi: 10.1016/j.bmc.2006.11.037. Epub 2006 Nov 29. Bioorg Med Chem. 2007. PMID: 17166721 Free PMC article.

7

High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists.

Schepetkin IA, Kirpotina LN, Khlebnikov AI, Quinn MT. Schepetkin IA, et al. Among authors: khlebnikov ai. Mol Pharmacol. 2007 Apr;71(4):1061-74. doi: 10.1124/mol.106.033100. Epub 2007 Jan 17. Mol Pharmacol. 2007. PMID: 17229869

8

N-benzoylpyrazoles are novel small-molecule inhibitors of human neutrophil elastase.

Schepetkin IA, Khlebnikov AI, Quinn MT. Schepetkin IA, et al. Among authors: khlebnikov ai. J Med Chem. 2007 Oct 4;50(20):4928-38. doi: 10.1021/jm070600+. Epub 2007 Sep 12. J Med Chem. 2007. PMID: 17850059

9

Structure-activity relationship analysis of N-benzoylpyrazoles for elastase inhibitory activity: a simplified approach using atom pair descriptors.

Khlebnikov AI, Schepetkin IA, Quinn MT. Khlebnikov AI, et al. Bioorg Med Chem. 2008 Mar 15;16(6):2791-802. doi: 10.1016/j.bmc.2008.01.014. Epub 2008 Jan 15. Bioorg Med Chem. 2008. PMID: 18234502 Free PMC article.

10

Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.

Schepetkin IA, Kirpotina LN, Tian J, Khlebnikov AI, Ye RD, Quinn MT. Schepetkin IA, et al. Among authors: khlebnikov ai. Mol Pharmacol. 2008 Aug;74(2):392-402. doi: 10.1124/mol.108.046946. Epub 2008 May 5. Mol Pharmacol. 2008. PMID: 18458054 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page